Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
IQVIA Holdings Inc (IQV)
NYSE:IQV
Holding IQV?
Track your performance easily
IQV Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$187.62 - $261.73
Previous Close$201.82
Volume2.20M
Average Volume (3M)1.45M
Market Cap
$36.63B
Enterprise Value$48.62B
Total Cash (Recent Filing)$1.71B
Total Debt (Recent Filing)$13.70B
Price to Earnings (P/E)26.5
Beta1.36
Next Earnings
Feb 12, 2025EPS Estimate
$3.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.62
Shares Outstanding181,500,000
10 Day Avg. Volume2,680,698
30 Day Avg. Volume1,447,919
Standard Deviation0.10
R-Squared0.62
Alpha-0.00727
Financial Highlights & Ratios
Price to Book (P/B)5.06
Price to Sales (P/S)2.27
Price to Cash Flow (P/CF)12.00
P/FCF Ratio12.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.17
Enterprise Value/Gross Profit9.28
Enterprise Value/Ebitda14.65
Forecast
1Y Price Target
$252.17Price Target Upside23.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
IQVIA Holdings News
Bulls Say, Bears Say
Bulls Say
Stock PerformanceManagement's commentary about excess stock buyback plans should tactically help support the stock.
Strategic PartnershipsIQV appears to be well positioned for continued share gains, with 100% large pharma strategic partnership retention and new strategic partnership wins.
Technology & Analytics Solutions (TAS) GrowthPositive improvements in the Technology & Analytics Solutions (TAS) segment continue to show signs of growth, exceeding the growth targets set by the company.
Bears Say
Earnings GuidanceIQV lowered 2024 guidance for all metrics due to macro headwinds and the Inflation Reduction Act causing R&DS guidance to be reduced.
Financial PerformanceIQV's 3Q results added to the recent volatility in biopharma demand with below-expectation B2B figures and further client restructurings anticipated.
Industry TrendsThere is increased uncertainty in the Contract Research Organization (CRO) industry due to a rise in cancellations and postponements.
---
Ownership Overview
0.81% Insiders
24.17% Mutual Funds
27.33% Other Institutional Investors
24.92% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IQV FAQ
What was IQVIA Holdings Inc’s price range in the past 12 months?
IQVIA Holdings Inc lowest stock price was $187.62 and its highest was $261.73 in the past 12 months.
What is IQVIA Holdings Inc’s market cap?
Currently, no data Available
When is IQVIA Holdings Inc’s upcoming earnings report date?
IQVIA Holdings Inc’s upcoming earnings report date is Feb 12, 2025 which is in 78 days.
How were IQVIA Holdings Inc’s earnings last quarter?
IQVIA Holdings Inc released its earnings results on Oct 31, 2024. The company reported $2.84 earnings per share for the quarter, beating the consensus estimate of $2.824 by $0.016.
Is IQVIA Holdings Inc overvalued?
According to Wall Street analysts IQVIA Holdings Inc’s price is currently Undervalued.
Does IQVIA Holdings Inc pay dividends?
IQVIA Holdings Inc does not currently pay dividends.
What is IQVIA Holdings Inc’s EPS estimate?
IQVIA Holdings Inc’s EPS estimate is $3.11.
How many shares outstanding does IQVIA Holdings Inc have?
IQVIA Holdings Inc has 181,500,000 shares outstanding.
What happened to IQVIA Holdings Inc’s price movement after its last earnings report?
IQVIA Holdings Inc reported an EPS of $2.84 in its last earnings report, beating expectations of $2.824. Following the earnings report the stock price went down -4.731%.
Which hedge fund is a major shareholder of IQVIA Holdings Inc?
Among the largest hedge funds holding IQVIA Holdings Inc’s share is Farallon Capital Management, L.L.C.. It holds IQVIA Holdings Inc’s shares valued at 751M.
---
IQVIA Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$252.17 (23.60% Upside)
$252.17 (23.60% Upside)
Blogger Sentiment
Bullish
IQV Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 182.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $320.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 3.4%
Last 30 Days ▲ 3.1%
Last 30 Days ▲ 3.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.67%
12-Months-Change
Fundamentals
Return on Equity
22.00%
Trailing 12-Months
Asset Growth
4.63%
Trailing 12-Months
Company Description
IQVIA Holdings Inc
North Carolina-based IQVIA Holdings, Inc. provides advanced analytics, technology solutions, and contract research services to the life sciences industry. The company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
---
IQV Company Deck
---
IQV Earnings Call
Q3 2024
0:00 / 0:00
---
IQV Revenue Breakdown
56.03% Research & Development Solutions
39.12% Technology & Analytics Solutions
4.85% Contract Sales & Medical Solutions
---
IQV Stock 12 Month Forecast
Average Price Target
$252.17
▲(23.60% Upside)
Technical Analysis
Best Analysts Covering IQV
1 Year
1 Year Success Rate
17/33 ratings generated profit
1 Year Average Return
+8.63%
reiterated a buy rating 8 days ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 51.52% of your transactions generating a profit, with an average return of +8.63% per trade.
---